1.
Pandya JN, Parmar J, Kaushik A, Desai S, Patel T, Meshram D. The Semaglutide Effect: Redefining Treatment Across Diabetes, Obesity, and Cardiometabolic Risk. Indian J Pharm Drug Studies. 2026;5(3):119-131. Accessed November 13, 2026. https://mansapublishers.com/ijpds/article/view/8465